A group of three miRNAs can act as candidate circulating biomarkers in liquid biopsies from melanoma patients.
Frontiers in medicine(2023)
摘要
Our results showed that three out seven miRNAs, namely and were differentially expressed in plasma-derived exosomes from melanoma patients and controls. Furthermore, the expression of the three miRNAs may be a promising ancillary tool as a melanoma biomarker, even for discriminating between nevi and melanoma.
更多查看译文
关键词
liquid biopsy, plasma, exosomes, miRNA, melanoma
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要